Is the Systolic Blood Pressure Intervention Trial (SPRINT) a breakthrough?
This recently published paper describes an open label, randomised controlled trial conducted at (n=102) sites in the US and Puerto Rico. The study aimed to answer the question of the optimal systolic blood pressure (SBP) strategy (target) in the prevention of cardiovascular events.